STOCKHOLM, Sweden--(BUSINESS WIRE)--In accordance with Biovitrum’s 2001/2006 warrant programme, 264,300 shares have been issued at SEK 59 per share, with net proceeds of SEK 15,593,700. The remaining 999,900 warrants under the 2001/2006 programme, each entitle to subscribe for two shares, expires on November 30, 2006.
